The global malaria diagnostics market is predicted to grow at a 4.6% CAGR over the forecast period, states the latest Market Research Future (MRFR) report. Malaria is a life-threating disease resulting from a parasite that is transmitted from the bite of infected anopheles’ mosquitoes. These infected mosquitoes transport the parasite. The moment such infected mosquitoes bite a person, the parasite gets released into their bloodstream. As the body becomes the host of these parasites, this passes to the liver and then matures. The mature parasites after a couple of days enter the bloodstream and begin infecting the red blood cells. People suffering from malaria experience weakness, headache, fever, and vomiting.
Malaria diagnostics is made through the microscopic test of the blood samples. Fever and other signs similar to malaria demand careful evaluation for diagnosing malaria. This diagnosis includes identifying antigens/products or malaria parasites in the patient’s blood. Accurate and prompt diagnosis is crucial for effective malaria management. Malaria diagnosis systems of superior quality is essential in every setting as misinterpretation or misdiagnosis can lead to mortality and substantial morbidity.
Various factors are propelling the malaria diagnostics market growth. Some of these factors, according to the Market Research Future report, include rapid technological advancements, increasing investments, an increasing number of healthcare facilities and hospitals, malaria drugs cost various government initiatives, and a burgeoning need for malaria diagnostics. Additional factors pushing market growth include the launch of new diagnostic techniques, rising incidences of malaria, increasing healthcare awareness, and an increase in migration and international travel.
On the contrary, scarcity of appropriate monitoring standards, weak regulatory framework, technological complications, growing need for low-cost diagnostic tests, and lack of awareness about malaria diagnosis are factors that may restrict the malaria diagnostics market growth over the forecast period.
Some of the key players in the global malaria diagnostics market are Access Bio. Inc., Abbott Laboratories, Premier Medical Corporation Pvt. Ltd, Sysmex Partec GmbH, bioMérieux, Beckman Coulter Inc., Siemens Healthineers, Leica Microsystems GmbH, Nikon Corporation, Olympus Corporation, and Bio-Rad Laboratories Inc.
The MRFR report offers a wide segmental analysis of the malaria diagnostics market on the basis of end user and technology.
Based on technology, the malaria diagnostics market is segmented into molecular diagnostics tests, microscopy, and rapid diagnostic tests. The molecular diagnostics tests are again segmented into real-time polymerase chain reaction (RT-PCR) and polymerase chain reaction (PCR). Of these, the rapid diagnostics test segment will have the largest share in the market over the forecast period.
Based on end users, the malaria diagnostics market is segmented into community healthcare, clinics, hospitals, and others.
The Americas is projected to lead the malaria diagnostics market in the forecast period. Increasing healthcare awareness, advancement in technology, medical tourism are some other factors that boost the growth of the market.
The European market is expected to hold the second largest market share. The European market is projected to grow because of the malaria cases brought in the European region by tourists and refugees. The European Centre for Disease Prevention and Control, stats reported a range of 5000 -7000 cases of malaria from 2008 to 2012.
Asia-Pacific is projected to be the fastest growing region for the global malaria diagnostics market in 2018. The market is expected to witness growth owing to the rising patient population, changing lifestyle, and growing elderly population. This is expected to provide favorable backgrounds for the market to grow. The diagnostic testing market, by volume, in India is controlled by microscopy testing. With increasing awareness and growing funding from care-based surveillance systems, private sectors and national governments the necessity for diagnostic testing procedures are projected to rise, thereby boosting the market development.
The Middle East and Africa accounts for the least share due to stringent government policies and low per capita income. Southeast Asia accounted for about 10% of the global cases, however, the death rate was around 7% in the same year.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071